SELECT MEDICAL HOLDINGS CORP(SEM)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,705 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
SEM Stock Analysis & AI Quality Score
Data updated 2026-08-29AI stock analysis and institutional research for SELECT MEDICAL HOLDINGS CORP (SEM), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SEM at 48.7/100 on a 32-signal composite quality model, placing it at rank #1,705 of 2,962 stocks — the bottom half of the AI-ranked universe. SEM scores in the top quartile across earnings quality (94.6), revenue scale (79.2). Areas of concern include institutional flow (4.9) and free cash flow (34.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), SELECT MEDICAL HOLDINGS CORP reports quarterly revenue of $1.4B, net income of $44.0M, an operating margin of 6.9%. Top institutional holders of SEM by reported 13-F value include BlackRock, Verition Fund Management, GLAZER CAPITAL, based on the most recent SEC filings. SEM trades on the NYSE exchange and files with the SEC under CIK 1320414. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SEM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for SELECT MEDICAL HOLDINGS CORP directly from SEC EDGAR. SELECT MEDICAL HOLDINGS CORP's 13F Pro composite quality score has ranged between 45 and 63 since 2021, currently 48.7 — a declining long-term trajectory across 67 quarterly and live scoring snapshots.
Revenue
Q1 2026
$1.4B
Net Income
Q1 2026
$44.0M
Free Cash Flow
Q1 2026
$-21.0M
Operating Margin
Q1 2026
6.9%
ROIC
Q1 2026
10.9%
D/E Ratio
Q1 2026
1.06
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+5.1% YoYNet Income
-31.7% YoYOperating Income
+25.3% YoYEPS (Diluted)
-30.1% YoYTotal Assets
+4.3% YoYTotal Debt
+6.8% YoYOp. Cash Flow
-33.1% YoYFree Cash Flow
-60.3% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.45B +5.1% | $5.19B +7.5% | $4.83B +4.7% | $4.61B -25.7% | $6.20B +12.2% | $5.53B |
| Net Income | $146.2M -31.7% | $214.0M -12.1% | $243.5M +53.1% | $159.0M -60.5% | $402.2M +55.3% | $259.0M |
| Operating Income | $336.2M +25.3% | $268.3M +0.4% | $267.2M +84.6% | $144.8M -79.7% | $713.8M +25.7% | $567.7M |
| EPS (Diluted) | $1.16 -30.1% | $1.66 -13.1% | $1.91 +55.3% | $1.23 -58.7% | $2.98 +54.4% | $1.93 |
| Total Assets | $5.85B +4.3% | $5.61B -27.1% | $7.69B +0.3% | $7.67B +4.1% | $7.36B -3.9% | $7.66B |
| Total Debt | $1.83B +6.8% | $1.71B -53.1% | $3.65B -5.8% | $3.88B +8.6% | $3.57B +5.1% | $3.40B |
| Operating Cash Flow | $346.5M -33.1% | $517.9M -11.0% | $582.1M +104.4% | $284.8M -29.0% | $401.2M -61.0% | $1.03B |
| Free Cash Flow | $117.2M -60.3% | $295.7M -16.2% | $352.9M +273.6% | $94.5M -57.2% | $220.7M -75.0% | $881.6M |
Get alerted when SEM's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for SELECT MEDICAL HOLDINGS CORP including:
Top Institutional Holders of SEM
BlackRock, Inc.
$215.8M13,073,640 shVerition Fund Management LLC
$198.5M12,025,235 shGLAZER CAPITAL, LLC
$177.3M10,744,069 shDIMENSIONAL FUND ADVISORS LP
$91.1M5,518,861 shTWO SIGMA INVESTMENTS, LP
$81.6M4,943,691 shWELLS FARGO & COMPANY/MN
$74.4M4,506,456 shAQR Arbitrage LLC
$47.6M2,880,889 shMILLENNIUM MANAGEMENT LLC
$45.5M2,754,016 shDecagon Asset Management LLP
$44.8M2,715,536 shPolar Asset Management Partners Inc.
$39.0M2,362,979 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $215.8M | 13,073,640 |
| Verition Fund Management LLC | $198.5M | 12,025,235 |
| GLAZER CAPITAL, LLC | $177.3M | 10,744,069 |
| DIMENSIONAL FUND ADVISORS LP | $91.1M | 5,518,861 |
| TWO SIGMA INVESTMENTS, LP | $81.6M | 4,943,691 |
| WELLS FARGO & COMPANY/MN | $74.4M | 4,506,456 |
| AQR Arbitrage LLC | $47.6M | 2,880,889 |
| MILLENNIUM MANAGEMENT LLC | $45.5M | 2,754,016 |
| Decagon Asset Management LLP | $44.8M | 2,715,536 |
| Polar Asset Management Partners Inc. | $39.0M | 2,362,979 |
Companies Similar to SEM
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
AVANOS MEDICAL, INC.
Organon & Co.
Huntsman CORP
National Vision Holdings, Inc.
Surgery Partners, Inc.
Option Care Health, Inc.
MOLINA HEALTHCARE, INC.
Esperion Therapeutics, Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put SEM on your watchlist
Track score changes the day SELECT MEDICAL HOLDINGS CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is SEM a good stock to buy?
13F Pro's AI-powered analysis of SELECT MEDICAL HOLDINGS CORP (SEM) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for SEM are available on the SEM stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. SEM is classified as a mid company.
Which hedge funds own SEM?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling SEM. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of SELECT MEDICAL HOLDINGS CORP's investment landscape.